Vancouver, British Columbia, November 23, 2022 — Burcon NutraScience Corporation (TSX: BU) a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce the results from its 2022 annual general meeting of shareholders (the “Meeting”) held on November 23, 2022. All of the eight nominees set out in Burcon’s management proxy circular dated October 5, 2022 proposed by management for election to the board of directors at the Meeting were elected to the board. Each director elected will hold office until the conclusion of the next annual general meeting of shareholders of Burcon or until his or her successor is elected or appointed, unless his or her office is earlier vacated in accordance with Burcon’s articles or with applicable law.
The results of the voting on the election of the directors are as follows:
| Director Nominee | Votes For | % Votes For | Votes Withheld | % Votes Withheld | Non Votes |
| David Lorne John Tyrrell | 29,960,618 | 96.74 | 1,008,935 | 3.26 | 3,108,312 |
| Alan Chan | 30,620,124 | 98.87 | 349,429 | 1.13 | 3,108,312 |
| J. Douglas Gilpin | 30,625,619 | 98.89 | 343,934 | 1.11 | 3,108,312 |
| Peter H. Kappel | 30,545,575 | 98.63 | 423,978 | 1.37 | 3,108,312 |
| Debora S. Fang | 30,006,440 | 96.89 | 963,113 | 3.11 | 3,108,312 |
| Jeanne McCaherty | 29,992,022 | 96.84 | 977,531 | 3.16 | 3,108,312 |
| Alfred Lau | 29,883,822 | 96.49 | 1,085,731 | 3.51 | 3,108,312 |
| Aaron T. Ratner | 30,607,029 | 98.83 | 362,524 | 1.17 | 3,108,312 |
Shareholders of the Company also approved the appointment of KPMG LLP as auditors of the Company.
Burcon is also pleased to announce that, Mr. Aaron T. Ratner was elected as a director of the Company. Ms. Rosanna Chau did not stand for re-election at the Meeting this year. The board of directors of Burcon would like to extend its gratitude to Ms. Chau for her valuable contributions to the board of Burcon during her tenure.
About Burcon NutraScience Corporation
Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. With over two decades of experience formulating high-purity proteins that have superior functionality, taste and nutrition, Burcon has amassed an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. In 2019, Merit Functional Foods Corporation (“Merit Foods”) was established between Burcon and three veteran food industry executives. Merit Foods has since built and commissioned a state-of-the-art protein production facility in Manitoba, Canada that is producing, under license from Burcon, best-in-class pea and canola proteins for the food and beverage industries. Burcon currently holds a 31.6% shareholding interest in Merit Foods. For more information, visit www.burcon.ca.
Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as “anticipate,” “intend,” “plan,” “goal,” “project,” “estimate,” “expect,” “believe,” “future,” “likely,” “may,” “should,” “could,” “will” and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon’s plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled “Risk Factors” in Burcon’s annual information form for the year ended March 31, 2022 and its other public filings with Canadian securities regulators on SEDAR at www.sedar.com. This list is not exhaustive of the factors that may affect any of the Company’s forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.
Industry and Investor Contact
Paul Lam
Director, Investor Relations
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267